Science
Mechanism of Action
LAUROYL PEI-233/POLYCAPROLACTONE COPOLYMER operates by facilitating the uniform distribution of solid particles in liquid matrices, preventing aggregation. Concurrently, it acts as an emulsifier, creating stable, homogeneous mixtures of typically incompatible oil and water phases. The hydrophobic polycaprolactone (PCL) segment of the copolymer is designed to form core-shell structures, effectively encapsulating and dispersing hydrophobic actives into aqueous environments.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
The stability of polycaprolactone (PCL) can be influenced by environmental pH conditions, though a specific optimal pH range for this copolymer has not been explicitly determined. Its emulsifying nature suggests robust functionality across both oil and water phases. While PCL itself is hydrophobic, its copolymerization enables dispersibility in aqueous solutions.
Safety
Safety Profile
Recognized as a novel ingredient, LAUROYL PEI-233/POLYCAPROLACTONE COPOLYMER is currently under safety classification review. Formal safety assessments by independent bodies such as CIR, SCCS, or FDA for the specific copolymer are not available. While polycaprolactone, a constituent, is generally considered non-toxic and biocompatible, the complete copolymer's safety profile requires comprehensive evaluation.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While LAUROYL PEI-233/POLYCAPROLACTONE COPOLYMER offers valuable emulsifying and dispersing properties for formulation stability, current data is insufficient to fully assess its safety and direct benefits for skin.
Related
Similar Ingredients
Finding similar ingredients…